Skip to main content

01.03.2017 | Demyelinating Disorders (DN Bourdette and M Cameron, Section Editors)

Dietary Interventions and Multiple Sclerosis

verfasst von: Ghadah Altowaijri, Allison Fryman, Vijayshree Yadav

Erschienen in: Current Neurology and Neuroscience Reports | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Multiple Sclerosis (MS) is a chronic, disabling neurologic disease that has its onset in young adulthood. While the knowledge about underlying pathogenesis of MS has improved significantly over the last few decades, the exact cause still eludes us. Despite the availability of several United States Food and Drug Administration-approved disease-modifying therapies (DMT) for MS in the last two decades, the disease remains disabling for many. DMT use is limited by its partial effectiveness, significant side effects in many cases, and high cost that leads people with MS (PwMS) to look for alternative management options. Dietary intervention as a possible mode to help MS seems very appealing to PwMS; however, scientific data supporting this notion remains sparse. New information on the role of various non-MS health factors, especially vascular disease risk factors such as hypertension, hyperlipidemia, salt intake, and obesity, that may play a role in MS pathogenesis appears very intriguing as it may partly explain the heterogeneity seen in MS activity and disability. This review will highlight the emerging information on various dietary approaches that may affect MS and their possible underlying mechanism.
Literatur
1.
Zurück zum Zitat Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors Ann Neurol. 2007;61:504–13.PubMed Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors Ann Neurol. 2007;61:504–13.PubMed
2.
Zurück zum Zitat van der Mei IA, Simpson Jr S, Stankovich J, Taylor BV. Individual and joint action of environmental factors and risk of MS. Neurol Clin. 2011;29:233–55.CrossRefPubMed van der Mei IA, Simpson Jr S, Stankovich J, Taylor BV. Individual and joint action of environmental factors and risk of MS. Neurol Clin. 2011;29:233–55.CrossRefPubMed
3.
Zurück zum Zitat Torkildsen O, Myhr KM, Bo L. Disease-modifying treatments for multiple sclerosis—a review of approved medications. Eur J Neurol. 2016;23 Suppl 1:18–27.CrossRefPubMed Torkildsen O, Myhr KM, Bo L. Disease-modifying treatments for multiple sclerosis—a review of approved medications. Eur J Neurol. 2016;23 Suppl 1:18–27.CrossRefPubMed
4.
Zurück zum Zitat Marrie RA, Rudick R, Horwitz R, et al. Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurology. 2010;74:1041–7.CrossRefPubMedPubMedCentral Marrie RA, Rudick R, Horwitz R, et al. Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurology. 2010;74:1041–7.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Weinstock-Guttman B, Baier M, Park Y, et al. Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients. Prostaglandins Leukot Essent Fatty Acids. 2005;73:397–404.CrossRefPubMed Weinstock-Guttman B, Baier M, Park Y, et al. Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients. Prostaglandins Leukot Essent Fatty Acids. 2005;73:397–404.CrossRefPubMed
6.
Zurück zum Zitat Hoare S, Lithander F, van der Mei I, Ponsonby AL, Lucas R, Ausimmune Investigator G. Higher intake of omega-3 polyunsaturated fatty acids is associated with a decreased risk of a first clinical diagnosis of central nervous system demyelination: results from the Ausimmune Study. Mult Scler. 2016;22:884–92.CrossRefPubMed Hoare S, Lithander F, van der Mei I, Ponsonby AL, Lucas R, Ausimmune Investigator G. Higher intake of omega-3 polyunsaturated fatty acids is associated with a decreased risk of a first clinical diagnosis of central nervous system demyelination: results from the Ausimmune Study. Mult Scler. 2016;22:884–92.CrossRefPubMed
7.
Zurück zum Zitat Riccio, P., & Rossano, R. (2015). Nutrition facts in multiple sclerosis. ASN neuro, 7(1), 1759091414568185 Riccio, P., & Rossano, R. (2015). Nutrition facts in multiple sclerosis. ASN neuro, 7(1), 1759091414568185
9.
Zurück zum Zitat • Hadgkiss EJ, Jelinek GA, Weiland TJ, Pereira NG, Marck CH, van der Meer DM. The association of diet with quality of life, disability, and relapse rate in an international sample of people with multiple sclerosis. Nutr Neurosci. 2015;18:125–36. Supports significant associations of healthy dietary habits with better quality of life for people with MS.CrossRefPubMedPubMedCentral • Hadgkiss EJ, Jelinek GA, Weiland TJ, Pereira NG, Marck CH, van der Meer DM. The association of diet with quality of life, disability, and relapse rate in an international sample of people with multiple sclerosis. Nutr Neurosci. 2015;18:125–36. Supports significant associations of healthy dietary habits with better quality of life for people with MS.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Weiland TJ, Jelinek GA, Marck CH, et al. Clinically significant fatigue: prevalence and associated factors in an international sample of adults with multiple sclerosis recruited via the internet. PLoS One. 2015;10:1–18. Weiland TJ, Jelinek GA, Marck CH, et al. Clinically significant fatigue: prevalence and associated factors in an international sample of adults with multiple sclerosis recruited via the internet. PLoS One. 2015;10:1–18.
11.
Zurück zum Zitat Schwarz S, Knorr C, Geiger H, Flachenecker P. Complementary and alternative medicine for multiple sclerosis. Mult Scler. 2008;14:1113–9.CrossRefPubMed Schwarz S, Knorr C, Geiger H, Flachenecker P. Complementary and alternative medicine for multiple sclerosis. Mult Scler. 2008;14:1113–9.CrossRefPubMed
12.
Zurück zum Zitat Farinotti M, Vacchi L, Simi S, Di Pietrantonj C, Brait L, Filippini G. Dietary interventions for multiple sclerosis. Cochrane Database Syst Rev. 2012;12:CD004192.PubMed Farinotti M, Vacchi L, Simi S, Di Pietrantonj C, Brait L, Filippini G. Dietary interventions for multiple sclerosis. Cochrane Database Syst Rev. 2012;12:CD004192.PubMed
13.
Zurück zum Zitat Dendrou CA, Fugger L, Friese MA. Immunopathology of multiple sclerosis. Nat Rev Immunol. 2015;15:545–58.CrossRefPubMed Dendrou CA, Fugger L, Friese MA. Immunopathology of multiple sclerosis. Nat Rev Immunol. 2015;15:545–58.CrossRefPubMed
14.
Zurück zum Zitat Karmon Y, Ramanathan M, Minagar A, Zivadinov R, Weinstock-Guttman B. Arterial, venous and other vascular risk factors in multiple sclerosis. Neurol Res. 2012;34:754–60.CrossRefPubMed Karmon Y, Ramanathan M, Minagar A, Zivadinov R, Weinstock-Guttman B. Arterial, venous and other vascular risk factors in multiple sclerosis. Neurol Res. 2012;34:754–60.CrossRefPubMed
15.
Zurück zum Zitat Guggenmos J, Schubart AS, Ogg S, et al. Antibody cross-reactivity between myelin oligodendrocyte glycoprotein and the milk protein butyrophilin in multiple sclerosis. J Immunol. 2004;172:661–8.CrossRefPubMed Guggenmos J, Schubart AS, Ogg S, et al. Antibody cross-reactivity between myelin oligodendrocyte glycoprotein and the milk protein butyrophilin in multiple sclerosis. J Immunol. 2004;172:661–8.CrossRefPubMed
16.
Zurück zum Zitat Marrie RA, Cohen J, Stuve O, et al. A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview. Mult Scler. 2015;21:1–19.CrossRef Marrie RA, Cohen J, Stuve O, et al. A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview. Mult Scler. 2015;21:1–19.CrossRef
17.
Zurück zum Zitat Marrie RA, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T. Comorbidity delays diagnosis and increases disability at diagnosis in MS. Neurology. 2009;72:117–24.CrossRefPubMedPubMedCentral Marrie RA, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T. Comorbidity delays diagnosis and increases disability at diagnosis in MS. Neurology. 2009;72:117–24.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Culpepper 2nd WJ, Wallin MT. Comorbidity increases the risk of hospitalizations in MS: prevention opportunities. Neurology. 2015;84:335–6.CrossRefPubMed Culpepper 2nd WJ, Wallin MT. Comorbidity increases the risk of hospitalizations in MS: prevention opportunities. Neurology. 2015;84:335–6.CrossRefPubMed
19.
Zurück zum Zitat Hedstrom AK, Olsson T, Alfredsson L. High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women. Mult Scler. 2012;18:1334–6.CrossRefPubMed Hedstrom AK, Olsson T, Alfredsson L. High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women. Mult Scler. 2012;18:1334–6.CrossRefPubMed
20.
Zurück zum Zitat Munger KL, Bentzen J, Laursen B, et al. Childhood body mass index and multiple sclerosis risk: a long-term cohort study. Mult Scler. 2013;19:1323–9.CrossRefPubMedPubMedCentral Munger KL, Bentzen J, Laursen B, et al. Childhood body mass index and multiple sclerosis risk: a long-term cohort study. Mult Scler. 2013;19:1323–9.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Wesnes K, Riise T, Casetta I, et al. Body size and the risk of multiple sclerosis in Norway and Italy: the EnvIMS study. Mult Scler. 2015;21:388–95.CrossRefPubMed Wesnes K, Riise T, Casetta I, et al. Body size and the risk of multiple sclerosis in Norway and Italy: the EnvIMS study. Mult Scler. 2015;21:388–95.CrossRefPubMed
22.
Zurück zum Zitat Marrie R, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T. High frequency of adverse health behaviors in multiple sclerosis. Mult Scler. 2009;15:105–13.CrossRefPubMed Marrie R, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T. High frequency of adverse health behaviors in multiple sclerosis. Mult Scler. 2009;15:105–13.CrossRefPubMed
23.
Zurück zum Zitat Khurana SR, Bamer AM, Turner AP, et al. The prevalence of overweight and obesity in veterans with multiple sclerosis. Am J Phys Med Rehabil. 2009;88:83–91.CrossRefPubMed Khurana SR, Bamer AM, Turner AP, et al. The prevalence of overweight and obesity in veterans with multiple sclerosis. Am J Phys Med Rehabil. 2009;88:83–91.CrossRefPubMed
24.
Zurück zum Zitat Altowaijri G, Wanchu. R., Bourdette, D., Yadav, V. Diets in multiple sclerosis: an overview. CML – Multiple Sclerosis 2015;7(2):29–40. Altowaijri G, Wanchu. R., Bourdette, D., Yadav, V. Diets in multiple sclerosis: an overview. CML – Multiple Sclerosis 2015;7(2):29–40.
25.
Zurück zum Zitat Hedstrom AK, Lima Bomfim I, Hillert J, Olsson T, Alfredsson L. Obesity interacts with infectious mononucleosis in risk of multiple sclerosis. Eur J Neurol. 2015;22:578–e538.CrossRefPubMed Hedstrom AK, Lima Bomfim I, Hillert J, Olsson T, Alfredsson L. Obesity interacts with infectious mononucleosis in risk of multiple sclerosis. Eur J Neurol. 2015;22:578–e538.CrossRefPubMed
26.
Zurück zum Zitat Matarese G, Carrieri PB, Montella S, De Rosa V, La Cava A. Leptin as a metabolic link to multiple sclerosis. Nat Rev Neurol. 2010;6:455–61.CrossRefPubMed Matarese G, Carrieri PB, Montella S, De Rosa V, La Cava A. Leptin as a metabolic link to multiple sclerosis. Nat Rev Neurol. 2010;6:455–61.CrossRefPubMed
27.
Zurück zum Zitat Baranowska-Bik A, Kochanowski J, Uchman D, et al. Association of copeptin and cortisol in newly diagnosed multiple sclerosis patients. J Neuroimmunol. 2015;282:21–4.CrossRefPubMed Baranowska-Bik A, Kochanowski J, Uchman D, et al. Association of copeptin and cortisol in newly diagnosed multiple sclerosis patients. J Neuroimmunol. 2015;282:21–4.CrossRefPubMed
28.
Zurück zum Zitat Tettey P, Simpson Jr S, Taylor B, et al. An adverse lipid profile is associated with disability and progression in disability, in people with MS. Mult Scler. 2014;20:1737–44.CrossRefPubMed Tettey P, Simpson Jr S, Taylor B, et al. An adverse lipid profile is associated with disability and progression in disability, in people with MS. Mult Scler. 2014;20:1737–44.CrossRefPubMed
29.
Zurück zum Zitat Weinstock-Guttman B, Zivadinov R, Horakova D, et al. Lipid profiles are associated with lesion formation over 24 months in interferon-beta treated patients following the first demyelinating event. J Neurol Neurosurg Psychiatry. 2013;84:1186–91.CrossRefPubMed Weinstock-Guttman B, Zivadinov R, Horakova D, et al. Lipid profiles are associated with lesion formation over 24 months in interferon-beta treated patients following the first demyelinating event. J Neurol Neurosurg Psychiatry. 2013;84:1186–91.CrossRefPubMed
30.
Zurück zum Zitat Browne RW, Weinstock-Guttman B, Horakova D, et al. Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes. J Neurol Neurosurg Psychiatry. 2014;85:859–64.CrossRefPubMed Browne RW, Weinstock-Guttman B, Horakova D, et al. Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes. J Neurol Neurosurg Psychiatry. 2014;85:859–64.CrossRefPubMed
31.
Zurück zum Zitat Plemel JR, Juzwik CA, Benson CA, Monks M, Harris C, Ploughman M. Over-the-counter anti-oxidant therapies for use in multiple sclerosis: a systematic review. Mult Scler. 2015;21:1485–95.CrossRefPubMed Plemel JR, Juzwik CA, Benson CA, Monks M, Harris C, Ploughman M. Over-the-counter anti-oxidant therapies for use in multiple sclerosis: a systematic review. Mult Scler. 2015;21:1485–95.CrossRefPubMed
33.
Zurück zum Zitat Gardener H, Wright CB, Gu Y, et al. Mediterranean-style diet and risk of ischemic stroke, myocardial infarction, and vascular death: the Northern Manhattan Study. Am J Clin Nutr. 2011;94:1458–64.CrossRefPubMedPubMedCentral Gardener H, Wright CB, Gu Y, et al. Mediterranean-style diet and risk of ischemic stroke, myocardial infarction, and vascular death: the Northern Manhattan Study. Am J Clin Nutr. 2011;94:1458–64.CrossRefPubMedPubMedCentral
34.
35.
Zurück zum Zitat Sacks, Frank M., et al. “Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet.” New England journal of medicine 344.1 (2001): 3–10 Sacks, Frank M., et al. “Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet.” New England journal of medicine 344.1 (2001): 3–10
36.
Zurück zum Zitat Farez MF, Fiol MP, Gaitan MI, Quintana FJ, Correale J. Sodium intake is associated with increased disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2015;86:26–31.CrossRefPubMed Farez MF, Fiol MP, Gaitan MI, Quintana FJ, Correale J. Sodium intake is associated with increased disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2015;86:26–31.CrossRefPubMed
37.
Zurück zum Zitat Kleinewietfeld M, Manzel A, Titze J, et al. Sodium chloride drives autoimmune disease by the induction of pathogenic Th17 cells. Nature. 2013;496:518–22.CrossRefPubMedPubMedCentral Kleinewietfeld M, Manzel A, Titze J, et al. Sodium chloride drives autoimmune disease by the induction of pathogenic Th17 cells. Nature. 2013;496:518–22.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Wahls TL AE. The Wahls protocol: how I beat progressive MS using Paleo principles and functional medicine. New York, NY: Penguin Group, 2014 Wahls TL AE. The Wahls protocol: how I beat progressive MS using Paleo principles and functional medicine. New York, NY: Penguin Group, 2014
39.
Zurück zum Zitat Manheimer EW, van Zuuren EJ, Fedorowicz Z, Pijl H. Paleolithic nutrition for metabolic syndrome: systematic review and meta-analysis. Am J Clin Nutr. 2015;102:922–32.CrossRefPubMedPubMedCentral Manheimer EW, van Zuuren EJ, Fedorowicz Z, Pijl H. Paleolithic nutrition for metabolic syndrome: systematic review and meta-analysis. Am J Clin Nutr. 2015;102:922–32.CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Bisht B, Darling WG, Grossmann RE, et al. A multimodal intervention for patients with secondary progressive multiple sclerosis: feasibility and effect on fatigue. J Altern Complement Med. 2014;20:347–55.CrossRefPubMedPubMedCentral Bisht B, Darling WG, Grossmann RE, et al. A multimodal intervention for patients with secondary progressive multiple sclerosis: feasibility and effect on fatigue. J Altern Complement Med. 2014;20:347–55.CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Bisht BD, WG., Shivapour ET., et al. Multimodal intervention improves fatigue and quality of life in subjects with progressive multiple sclerosis: a pilot study. Degener Neurol Neuromuscul Dis 2015;5:19–35 Bisht BD, WG., Shivapour ET., et al. Multimodal intervention improves fatigue and quality of life in subjects with progressive multiple sclerosis: a pilot study. Degener Neurol Neuromuscul Dis 2015;5:19–35
42.
Zurück zum Zitat Swank RL, Dugan, B. B. The multiple sclerosis diet book.: Doubleday, 1987 Swank RL, Dugan, B. B. The multiple sclerosis diet book.: Doubleday, 1987
43.
Zurück zum Zitat Swank RL. Multiple sclerosis; a correlation of its incidence with dietary fat. Am J Med Sci. 1950;220:421–30.CrossRefPubMed Swank RL. Multiple sclerosis; a correlation of its incidence with dietary fat. Am J Med Sci. 1950;220:421–30.CrossRefPubMed
44.
Zurück zum Zitat Swank RL, Lerstad O, Strom A, Backer J. Multiple sclerosis in rural Norway its geographic and occupational incidence in relation to nutrition. N Engl J Med. 1952;246:722–8.CrossRefPubMed Swank RL, Lerstad O, Strom A, Backer J. Multiple sclerosis in rural Norway its geographic and occupational incidence in relation to nutrition. N Engl J Med. 1952;246:722–8.CrossRefPubMed
45.
Zurück zum Zitat Swank RL, Goodwin J. Review of MS patient survival on a Swank low saturated fat diet. Nutrition. 2003;19:161–2.CrossRefPubMed Swank RL, Goodwin J. Review of MS patient survival on a Swank low saturated fat diet. Nutrition. 2003;19:161–2.CrossRefPubMed
46.
Zurück zum Zitat Swank RL, Dugan BB. Effect of low saturated fat diet in early and late cases of multiple sclerosis. Lancet. 1990;336:37–9.CrossRefPubMed Swank RL, Dugan BB. Effect of low saturated fat diet in early and late cases of multiple sclerosis. Lancet. 1990;336:37–9.CrossRefPubMed
47.
Zurück zum Zitat Swank RL. Multiple sclerosis: fat-oil relationship. Nutrition. 1991;7:368–76.PubMed Swank RL. Multiple sclerosis: fat-oil relationship. Nutrition. 1991;7:368–76.PubMed
48.
Zurück zum Zitat McDougall JA MM. The starch solution: eat the foods you love, regain your health, and lose the weight for good! Emmaus, PA: Rodale Press, 2012 McDougall JA MM. The starch solution: eat the foods you love, regain your health, and lose the weight for good! Emmaus, PA: Rodale Press, 2012
49.
Zurück zum Zitat • Yadav V MG, Kim E, et al. Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial. Multiple Sclerosis and Related Disorders 2016;9:80–90. Only randomized controlled study that used MRI brain as key outcome and showed significant fatigue improvement with dietary change. • Yadav V MG, Kim E, et al. Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial. Multiple Sclerosis and Related Disorders 2016;9:80–90. Only randomized controlled study that used MRI brain as key outcome and showed significant fatigue improvement with dietary change.
50.
Zurück zum Zitat • Yadav V, Bever Jr C, Bowen J, et al. Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of the guideline development subcommittee of the American Academy of Neurology. Neurology. 2014;82:1083–92. Includes the most comprehensive and evidence based analysis of dietary interventions in MS.CrossRefPubMedPubMedCentral • Yadav V, Bever Jr C, Bowen J, et al. Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of the guideline development subcommittee of the American Academy of Neurology. Neurology. 2014;82:1083–92. Includes the most comprehensive and evidence based analysis of dietary interventions in MS.CrossRefPubMedPubMedCentral
51.
Zurück zum Zitat Esquifino AI, Cano P, Jimenez-Ortega V, Fernandez-Mateos MP, Cardinali DP. Immune response after experimental allergic encephalomyelitis in rats subjected to calorie restriction. J Neuroinflammation. 2007;4:6.CrossRefPubMedPubMedCentral Esquifino AI, Cano P, Jimenez-Ortega V, Fernandez-Mateos MP, Cardinali DP. Immune response after experimental allergic encephalomyelitis in rats subjected to calorie restriction. J Neuroinflammation. 2007;4:6.CrossRefPubMedPubMedCentral
52.
53.
Zurück zum Zitat Riccio P, Rossano R, Larocca M, et al. Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: a pilot study. Exp Biol Med (Maywood). 2016;241:620–35.CrossRef Riccio P, Rossano R, Larocca M, et al. Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: a pilot study. Exp Biol Med (Maywood). 2016;241:620–35.CrossRef
54.
Zurück zum Zitat Calorie Restriction in Multiple Sclerosis Patients. [online]. Available at: clinicaltrials.gov identifier: NCT02411838. Accessed 13 July 2015. Calorie Restriction in Multiple Sclerosis Patients. [online]. Available at: clinicaltrials.gov identifier: NCT02411838. Accessed 13 July 2015.
55.
Zurück zum Zitat A Pilot Trial to Test the Feasibility of Prolonged Fasting and Ketogenic Diet in Relapsing–Remitting Multiple Sclerosis (IGEL). Available at: clinicaltrials.gov identifier: NCT NCT01538355 A Pilot Trial to Test the Feasibility of Prolonged Fasting and Ketogenic Diet in Relapsing–Remitting Multiple Sclerosis (IGEL). Available at: clinicaltrials.gov identifier: NCT NCT01538355
56.
Zurück zum Zitat Bhargava P, Mowry EM. Gut microbiome and multiple sclerosis. Curr Neurol Neurosci Rep. 2014;14:492.CrossRefPubMed Bhargava P, Mowry EM. Gut microbiome and multiple sclerosis. Curr Neurol Neurosci Rep. 2014;14:492.CrossRefPubMed
57.
Zurück zum Zitat Langer-Gould A, Brara SM, Beaber BE, Koebnick C. Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome. Neurology. 2013;80:548–52.CrossRefPubMedPubMedCentral Langer-Gould A, Brara SM, Beaber BE, Koebnick C. Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome. Neurology. 2013;80:548–52.CrossRefPubMedPubMedCentral
58.
Zurück zum Zitat De Filippo C, Cavalieri D, Di Paola M, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A. 2010;107:14691–6.CrossRefPubMedPubMedCentral De Filippo C, Cavalieri D, Di Paola M, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A. 2010;107:14691–6.CrossRefPubMedPubMedCentral
Metadaten
Titel
Dietary Interventions and Multiple Sclerosis
verfasst von
Ghadah Altowaijri
Allison Fryman
Vijayshree Yadav
Publikationsdatum
01.03.2017
Verlag
Springer US
Erschienen in
Current Neurology and Neuroscience Reports / Ausgabe 3/2017
Print ISSN: 1528-4042
Elektronische ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-017-0732-3

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.